(Press-News.org) An Icahn School of Medicine at Mount Sinai study sheds light on the intricate interplay between mammary adipose (fat) tissue and breast health, and offers exciting possibilities for understanding breast development, lactation, cancer, and obesity and related metabolic disorders.
The study was published today in Nature. The research team was led by Prashant Rajbhandari, PhD, Assistant Professor of Medicine (Endocrinology, Diabetes and Bone Disease), and a member of the Diabetes, Obesity, and Metabolism Institute at Icahn Mount Sinai.
The researchers discovered a new family of locally secreted and locally acting molecules in the breast called “mammokines” that contribute not only to normal mammary biology, but to overall fat cell physiology and energy balance control.
Mammary adipose tissue has long been recognized for its essential role in breast biology. It consists of many different cell types, including fat cells (adipocytes), immune cells, sympathetic nerve fibers, and mammary epithelial cells forming a milk-producing ductal system. Mammary adipocytes play important roles in organizing mammary ducts, and the reverse is true as well.
The new studies reveal an unexpected role for nerve-activated ductal cells in mammary adipocyte metabolism and heat generation. These mammary duct-secreted mammokines play an important role in controlling mammary gland fat abundance and could potentially orchestrate critical processes involved in breast development, lactation, and overall whole-body metabolic regulation. The findings thus have important implications for breast cancer, lactation-related disorders, newborn health, and metabolic syndromes linked to mammary adipose dysfunction.
“The discovery of mammokines is a significant milestone in our quest to comprehend the complex interplay between mammary adipose tissue and breast biology,” says Dr. Rajbhandari “This breakthrough opens up new avenues for developing targeted interventions to improve breast health and combat related metabolic disorders.”
The research team is currently focused on working to further identify new mammokines and characterize each of them. Their primary aim is to decipher the precise roles of these mammokines and determine whether they regulate systemic glucose and insulin homeostasis through communication with the brain, liver, and pancreas. Additionally, the team is exploring potential therapeutic applications for diseases related to the breast and metabolism.
“This work holds enormous promise for future advancements in women's health and metabolic research and the development of personalized treatment strategies based on mammokine profiling,” said Andrew Stewart, MD, Director of the Diabetes, Obesity, and Metabolism Institute at Icahn Mount Sinai.
This discovery is the result of the collaborative efforts of a large team of researchers with diverse areas of expertise in the United States and Europe. Research contributors include Sanil Patel, MS; Njeri Z.R. Sparman, BS; Alexandra Alvarsson, PhD; Luís C. Santos, PhD; Samuel J. Duesman, PhD; Chung Hwan Cho, PhD; Ephraim Hathaway, BS; Abha K. Rajbhandari, PhD; Peng Wang, PhD; Leigh Goedeke, PhD; Sarah A. Stanley, PhD, and Prashant Rajbhandari, PhD, Icahn Mount Sinai, along with Douglas Arneson, PhD; In Sook Ahn, PhD; Graciel Diamante, PhD; Ingrid Cely, BS; Xia Yang, PhD, and Aldons J. Lusis, PhD, University of California, Los Angeles; Alessia Centonze, PhD, and Cédric Blanpain, PhD, Université Libre de Bruxelles; Noble Kumar Talari, PhD, and Karthickeyan Chella Krishnan, PhD, University of Cincinnati College of Medicine, plus Atul J. Butte, PhD, University of California, San Francisco.
Dr. Rajbhandari is supported by The Icahn School of Medicine at Mount Sinai Seed Fund, DK114571, NIDDK-supported Einstein-Sinai Diabetes Research Center (DRC) Pilot & Feasibility Award, and Diabetes Action Research and Education Foundation (DREF) Grant #501. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.
Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 44 academic departments and 36 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.
Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.
A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.
Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.
Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.
The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
END
Mount Sinai researchers uncover how mammary glands control overall energy balance and fat metabolism
2023-07-26
ELSE PRESS RELEASES FROM THIS DATE:
Study in journal Nature Communications finds high blood glucose levels sensitizes pancreatic cancer cells to chemotherapy
2023-07-26
CLEVELAND - Pancreatic cancer is one of the most difficult cancers to treat, being highly resistant to chemotherapy.
However, there are no effective alternative therapies to chemotherapy, so chemo remains the best available treatment.
Although there are fewer than roughly 60,000 new cases of pancreatic cancer diagnosed annually in the U.S., about 95 percent of people with it die from it, mainly because it often goes undetected in early stages.
Approved multi-agent chemotherapy regimens offer a marginal advance over single-agent ...
Global wildlife trade risks altering evolutionary history and ecosystem function, study suggests
2023-07-26
Some of the world’s most distinct and ancient animal species, which play crucial roles in our planet’s ecosystems, are exploited for the wildlife trade across large parts of the world, according to new research from the University of Sheffield.
The study, led by researchers from the University’s School of Biosciences, has found that in large areas of the world, a wide range of functionally and evolutionarily distinct species are targeted for the wildlife trade, which has the potential to cause major losses of evolutionary history and alter key ecological processes.
Published in Nature, the ...
For people with diabetes, healthy eating is not enough if their diet is rich in ultra-processed foods
2023-07-26
The very first rule for people diagnosed with type 2 diabetes is to eat a healthy nutritious diet. Attention to ingested calories, as well as nutrients contained in various foods, become integral parts of a diabetic person's life. However, this might not be enough: an important role in determining the future health status of people with this condition could be played by the degree of processing of foods that end up on the dish. These products are described as "ultra-processed" and are associated with adverse health outcomes, as reported in general population studies.
A study conducted by the Department of Epidemiology and Prevention at the I.R.C.C.S. Neuromed in Pozzilli, ...
Keck Hospital of USC receives highest rating on national quality report
2023-07-26
LOS ANGELES, CA — Keck Hospital of USC earned five stars, the highest rating possible, on the Centers for Medicare & Medicaid Services (CMS) 2023 quality star rating report.
Only approximately 16% of hospitals across the country, 483 out of 3,076, received five stars out of a one-to-five-star rating system.
“This prestigious designation demonstrates our continuing commitment to patient safety and to best patient outcomes, and is the result of the hard work of every physician, nurse and staff member at the hospital,” said Stephanie Hall, MD, MHA, chief medical officer ...
Earlier and earlier high-Arctic spring replaced by “extreme year-to-year variation”
2023-07-26
About 15 years ago, researchers reported that the timing of spring in high-Arctic Greenland had advanced at some of the fastest rates of change ever seen anywhere in the world. But, according to new evidence reported in the journal Current Biology on July 26, that earlier pattern has since been completely erased. Instead of coming earlier and earlier, it seems the timing of Arctic spring is now driven by tremendous climate variability with drastic differences from one year to the next.
“As scientists we are obliged to revisit previous ...
Mapping mass shootings in the United States
2023-07-26
The United States has more than 10 times the number of mass shooting incidents than other developed countries, yet little research has shown the distribution and types of shootings, geographically.
“I’m constantly asked, ‘What is public health doing about the rise in mass shootings?” says Leslie Barnard, MPH, a student working with the University of Colorado School of Medicine’s Firearm Injury Prevention Initiative.
Barnard, a doctoral candidate in the Department of Epidemiology in the Colorado School of Public Health at the CU Anschutz Medical Campus, wanted to find answers to address public ...
Eight out of ten child deaths in low-income countries could be prevented
2023-07-26
Eighty-two percent of child deaths in low-income countries could be prevented, according to a study from the international CHAMPS network published in JAMA Network Open. The study, which used the minimally invasive autopsy technique developed by the Barcelona Institute for Global Health (ISGlobal), found an infectious agent in 87% of cases and identified malnutrition as the most common underlying cause of death.
Ninety-nine percent of deaths in children under five years of age occur in low- and middle-income countries. "If we want to prevent these deaths, we need to know the causes, but the problem is that we lack reliable data," says Quique Bassat, ...
Use of wastewater metrics to track COVID-19
2023-07-26
About The Study: The findings of this study including 268 counties in 22 states suggest that wastewater surveillance can provide an accurate assessment of county SARS-CoV-2 incidence and may be the best metric for monitoring amount of circulating virus as home testing increases and disease acuity decreases because of vaccination and treatment.
Authors: Meri R. J. Varkila, M.D., of Stanford University in Palo Alto, California, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.25591)
Editor’s Note: Please ...
Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people
2023-07-26
About The Study: This secondary analysis of a randomized clinical trial including 19,000 older adults found a significant increase in intracranial bleeding with daily low-dose aspirin but no significant reduction of ischemic stroke. These findings may have particular relevance to older individuals prone to developing intracranial bleeding after head trauma (e.g., from falls).
Authors: John J. McNeil, Ph.D., of Monash University in Melbourne, Australia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.25803)
Editor’s ...
Global warming will cause more multiyear La Niña events: study
2023-07-26
The El Niño–Southern Oscillation (ENSO) is the Earth's most consequential interannual climate fluctuation. Alternating irregularly between warm El Niño and cold La Niña phases, it brings shifts in ocean surface temperature and disrupts wind and rainfall patterns across the tropics.
Unlike El Niño, which usually lasts one year, La Niña tends to develop after an El Niño and lasts for two consecutive years or more. This is known as a multiyear La Niña event and exerts prolonged and aggregated impacts, such as increased wildfires, flooding, and altered ...